Cargando…

Expression and clinical prognostic value of m6A RNA methylation modification in breast cancer

BACKGROUND: N6-methyladenosine(m6A) methylation modification affects the tumorigenesis, progression, and metastasis of breast cancer (BC). However, the expression characteristics and prognostic value of m6A modification in BC are still unclear. We aimed to evaluate the relationship between m6A modif...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zheng, Fangchao, Du, Feng, Qian, Haili, Zhao, Jiuda, Wang, Xue, Yue, Jian, Hu, Nanlin, Si, Yiran, Xu, Binghe, Yuan, Peng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8082898/ https://www.ncbi.nlm.nih.gov/pubmed/33926554 http://dx.doi.org/10.1186/s40364-021-00285-w

Ejemplares similares

The emerging role of RNA N6-methyladenosine methylation in breast cancer
por: Zheng, Fangchao, et al.
Publicado: (2021)

Clinicopathological Differences and Prognostic Value of Hypoxia-Inducible Factor-2α Expression for Gastric Cancer: Evidence From Meta-Analysis
por: Zheng, Fangchao, et al.
Publicado: (2016)

Durable Disease-free Survival in a Patient with Metastatic Triple-negative Breast Cancer Treated with Olaparib Monotherapy
por: Wang, Xue, et al.
Publicado: (2022)

A Phase II, Single-Arm Study of Apatinib and Oral Etoposide in Heavily Pre-Treated Metastatic Breast Cancer
por: Hu, Nanlin, et al.
Publicado: (2021)

Emerging role of m6A methylation modification in ovarian cancer
por: Chang, Lin-Lin, et al.
Publicado: (2021)

Novel Immune-Related Gene Signature for Risk Stratification and Prognosis of Survival in ER (+) and/or PR (+) and HER2 (−) Breast Cancer
por: Du, Feng, et al.
Publicado: (2022)

The functions and prognostic values of m6A RNA methylation regulators in thyroid carcinoma
por: Yu, Zhi-Hao, et al.
Publicado: (2021)

Prognostic values of m6A RNA methylation regulators in differentiated Thyroid Carcinoma
por: Xu, Nizhen, et al.
Publicado: (2020)

Anlotinib has good efficacy and low toxicity: a phase II study of anlotinib in pre-treated HER-2 negative metastatic breast cancer
por: Hu, Nanlin, et al.
Publicado: (2021)

Primary Tumor Surgery for Patients with De Novo Stage IV Breast Cancer can Decrease Local Symptoms and Improve Quality of Life
por: Si, Yiran, et al.
Publicado: (2020)

Malignant Evaluation and Clinical Prognostic Values of m6A RNA Methylation Regulators in Glioblastoma
por: Du, Jianyang, et al.
Publicado: (2020)

The prognostic values of m6A RNA methylation regulators in uveal melanoma
por: Tang, Jing, et al.
Publicado: (2020)

The Prognostic Value of m6A RNA Methylation Regulators in Colon Adenocarcinoma
por: Liu, Tao, et al.
Publicado: (2019)

m5C methylation modification guides the prognostic value and immune landscapes in acute myeloid leukemia
por: Liu, Ya, et al.
Publicado: (2023)

Identification of Critical m(6)A RNA Methylation Regulators with Prognostic Value in Lower-Grade Glioma
por: Zheng, Jianglin, et al.
Publicado: (2021)

Expression Pattern and Prognostic Value of Key Regulators for m6A RNA Modification in Hepatocellular Carcinoma
por: Zhang, Lele, et al.
Publicado: (2020)

Meta-Analysis of HER2-Enriched Subtype Predicting the Pathological Complete Response Within HER2-Positive Breast Cancer in Patients Who Received Neoadjuvant Treatment
por: Shen, Guoshuang, et al.
Publicado: (2021)

RNA Modification by m(6)A Methylation in Cardiovascular Disease
por: Chen, Jun, et al.
Publicado: (2021)

Elucidating the clinical and immunological value of m6A regulator-mediated methylation modification patterns in adrenocortical carcinoma
por: XU, WENHAO, et al.
Publicado: (2023)

Expression patterns and prognostic value of m(6)A RNA methylation regulators in adrenocortical carcinoma
por: Fu, Yang, et al.
Publicado: (2021)

Gene Signatures and Prognostic Values of m6A RNA Methylation Regulators in Ovarian Cancer
por: Han, Xiao, et al.
Publicado: (2020)

Expression Status and Prognostic Value of m(6)A RNA Methylation Regulators in Lung Adenocarcinoma
por: Li, Xiuhong, et al.
Publicado: (2021)

Four m6A RNA Methylation Gene Signatures and Their Prognostic Values in Lung Adenocarcinoma
por: Wang, Yuzhu, et al.
Publicado: (2022)

Expression and Prognostic Value of m6A RNA Methylation-Related Genes in Thyroid Cancer
por: Han, Hui, et al.
Publicado: (2023)

The metastasis patterns and their prognostic features in patients with de novo metastatic breast cancer of different ages
por: Sun, Shujuan, et al.
Publicado: (2023)

Phase-Transformation Nanoparticle-Mediated Sonodynamic Therapy: An Effective Modality to Enhance Anti-Tumor Immune Response by Inducing Immunogenic Cell Death in Breast Cancer
por: Si, Yiran, et al.
Publicado: (2021)

Novel insight into m6A regulator-mediated methylation modification patterns and immune characteristics in intracranial aneurysm
por: Li, Shifu, et al.
Publicado: (2022)

N6-methyladenosine RNA modification (m6A) is of prognostic value in HPV-dependent vulvar squamous cell carcinoma
por: Condic, Mateja, et al.
Publicado: (2022)

Emerging roles of N6-methyladenosine (m(6)A) modification in breast cancer
por: Wang, Yanyan, et al.
Publicado: (2020)

Prognostic and therapeutic implication of m6A methylation in Crohn disease
por: He, Yujin, et al.
Publicado: (2022)

Impact on long-term survival of the number of lymph nodes resected in patients with pT1N0 gastric cancer after R0 resection: A multicenter study in China
por: Zhao, Jiuda, et al.
Publicado: (2016)

m6A Regulator-Mediated Methylation Modification Patterns and Characteristics in COVID-19 Patients
por: Qing, Xin, et al.
Publicado: (2022)

Prognostic Value of an m6A RNA Methylation Regulator-Based Signature in Patients with Hepatocellular Carcinoma
por: Wu, Xiaomin, et al.
Publicado: (2020)

Gene Expression Profile and Prognostic Value of m6A RNA Methylation Regulators in Hepatocellular Carcinoma
por: Chang, Xian, et al.
Publicado: (2021)

Malignant Evaluation and Clinical Prognostic Values of M6A RNA Methylation Regulators in Prostate Cancer
por: Zhang, Qijie, et al.
Publicado: (2021)

Potential role of m6A RNA methylation regulators in osteosarcoma and its clinical prognostic value
por: Liu, Hua, et al.
Publicado: (2021)

Association between homologous recombination deficiency and outcomes with platinum and platinum-free chemotherapy in patients with triple-negative breast cancer
por: Chen, Yimeng, et al.
Publicado: (2023)

m6A-Mediated Tumor Invasion and Methylation Modification in Breast Cancer Microenvironment
por: Liu, Fei, et al.
Publicado: (2021)

Contributions and Prognostic Values of N6-Methyladenosine RNA Methylation Regulators in Hepatocellular Carcinoma
por: Qi, Li-Wen, et al.
Publicado: (2021)

The Role of N(6)-Methyladenosine (m(6)A) Methylation Modifications in Hematological Malignancies
por: Zhao, Yan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_s0hr4ov78gs5pvm2po31jco9oq